Recent news on Repaglinide

New Type 2 Drugs Januvia and Byetta Offer Big Benefits  -  May 2, 2007
Diabetes Health (press release),...attractive alternative for recently diagnosed diabetics who would otherwise receive a sulfonylurea, such as Novo Nordisk Inc.’s Prandin (repaglinide).

Oral medications to treat Type 2 diabetes  -  Apr 19, 2007
Chennai Online,Repaglinide (brand name Prandin made by Novo Nordisk), Nateglinide (sold as Starlix by Novartis), and mitiglinide (sold by Takeda/Kissei as Glufast in

Novo Nordisk stop small molecule drug development  -  Jan 17, 2007
In-PharmaTechnologist.com,Oral antidiabetic products that are already marketed, including Prandin (repaglinide) (or Novonorm outside the US), will be retained, though they only count

Novo Nordisk Withdraws Its Application To Extend The Marketing ...  Oct 18, 2006
...notified by Novo Nordisk A/S of its decision to withdraw its application for a change to the marketing authorisations for NovoNorm (repaglinide) and Prandin ... -Medical News Today (press release), Torrent Signs agreement with Tasly to market Cardio-tonic Pill  Oct 11, 2006
The Company was the first to launch global blockbusters like Atenolol, Rosiglitazone and Repaglinide in India and enjoys market leadership in many brands in ... -Equity Bulls, Torrent signs in-licensing deal to market Chinese cardiac ...  Oct 11, 2006
Torrent says that it was the first to launch global blockbusters like atenolol, rosiglitazone and repaglinide in India and enjoys market leadership in many ... -domain-B, NovoNorm may offer advantages in elderly diabetics  Aug 10, 2006
NEW YORK (Reuters Health) - In elderly patients with type 2 or non-insulin dependent diabetes, treatment with the short-acting drug repaglinide (NovoNorm) may ... -Reuters.uk

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional